USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
TRANSPARENT MATERIALS, LLC
Address:
1699 Lake Ave
Bldg. 59, R204, MC 01720
Rochester, NY 14650-1720
Phone:
N/A
URL:
N/A
EIN:
800293516
DUNS:
828749759
Number of Employees:
6
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $335,612.00 2
SBIR Phase II $467,551.00 1

Award List:

SBIR Phase I: Innovations in Nanoscale Manufacturing: Assembly of Nanomaterial Components via Electrostatic Forces and Production of Composites for Bio-Medical Implants.

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$185,612.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research Phase I project seeks to develop nanomanufacturing methods for producing metal-oxide composites for biomedical implants. Homogeneous, mixed metal-oxide composites are extremely difficult to prepare by existing processes, and although of great utility,… More

SBIR Phase II: Innovations in Nanoscale Manufacturing: Nanomaterial Composites for Dental Restorations

Award Year / Program / Phase:
2011 / SBIR / Phase II
Award Amount:
$467,551.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research (SBIR) Phase II project seeks to develop nanomanufacturing methods for producing nanocomposites for use in dentistry. Nanocomposites have shown great promise in dentistry but have limited applications because of the lack of reliable manufacturing methods to… More

SBIR Phase I: Bioactive, High-Strength Contrast Agents for Orthopedic and Bone Applications

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$150,000.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research (SBIR) Phase I project seeks to develop bioactive, high-strength contrast agents for use in orthopedic and bone implant applications. There is a clear clinical need for improved contrast agents that increase the strength, toughness and abrasion wear of… More